Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children

PHASE3UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 23, 2017

Primary Completion Date

November 23, 2019

Study Completion Date

March 31, 2023

Conditions
Peanut Allergy
Interventions
DRUG

Viaskin Peanut 250µg

DBV712 250 µg, once daily

Trial Locations (31)

10029

Jaffe Food Allergy Institute, New York

15213

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

21205

Johns Hopkins Hospital, Baltimore

27599

The University of North Carolina - Chapell Hill, Chapel Hill

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

60611

Ann & Robert Lurie Children's Hospital of Chicago, Chicago

72202

Arkansas Children's Hospital, Little Rock

77030

Baylor College of Medicine - Texas Children's Hospital, Houston

80045

Children's Hospital Colorado, Aurora

80206

National Jewish Health, Denver

91054

Universitätsklinikum Erlangen, Erlangen

92123

University of California, Rady Children's Hospital, San Diego

94304

Stanford University School of Medicine, Stanford

98115

ASTHMA, Inc., Seattle

02114

Massachusetts General Hospital, Boston

02115

Boston Childrens' Hospital, Boston

75390-9105

Children's Medical Center of Dallas, Dallas

Unknown

Allergy Medical, Brisbane

Princess Margaret Hospital for Children, Perth

Children's Hospital Westmead, Sydney

Clinical Investigations Unit, Cork

Our Lady's Children's Hospital, Dublin

V5H 3V4

British Columbia Children's Hospital, Vancouver

L5A 3V4

Cheema Research Inc., Mississauga

K1G 6C6

Ottawa Allergy Asthma Research Institute, Ottawa

M4V 1R2

Gordon Sussman Clinical Research Inc., Toronto

H3T 1C4

CHUM & CHU Sainte-Justine, Montreal

QC G1V4M6

Centre de Recherche Appliquée en Allergie de Quebec, Québec

D13353

Charité Universitätsmedizin Berlin, Berlin

D-53115

St.-Marien-Hospital, Bonn

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DBV Technologies

INDUSTRY

NCT03013517 - Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children | Biotech Hunter | Biotech Hunter